The Discounted Cash Flow (DCF) valuation of Elite Pharmaceuticals Inc (ELTP) is 0.07 USD. With the latest stock price at 0.53 USD, the upside of Elite Pharmaceuticals Inc based on DCF is -87.3%.
Based on the latest price of 0.53 USD and our DCF valuation, Elite Pharmaceuticals Inc (ELTP) is a sell. selling ELTP stocks now will result in a potential gain of 87.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 9.7% | 7.9% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 0.05 - 0.12 | 0.07 |
| Upside | -91.2% - -76.6% | -87.3% |